Difference between revisions of "Main Page/SlicerCommunity"
| Line 11: | Line 11: | ||
*[https://scholar.google.com/scholar?hl=en&as_sdt=1%2C22&as_vis=1&q=%28cancer+OR+tumor+OR+radiation%29+AND+%28%223D+Slicer%22+OR+%22slicer+org%22+OR+Slicer3D%29+-Slic3r+&btnG= 5200+ cancer research citations on Google Scholar] ([https://scholar.google.com/scholar?hl=en&as_sdt=1%2C22&as_vis=1&q=%28prostate%29+AND+%28cancer+OR+tumor+OR+radiation%29+AND+%28%223D+Slicer%22+OR+%22slicer+org%22+OR+Slicer3D%29+-Slic3r+&btnG= 1250+ prostate]), ([https://scholar.google.com/scholar?hl=en&as_sdt=1%2C22&as_vis=1&q=%28brain%29+AND+%28cancer+OR+tumor+OR+radiation%29+AND+%28%223D+Slicer%22+OR+%22slicer+org%22+OR+Slicer3D%29+-Slic3r+&btnG= 2,900+ brain]), ([https://scholar.google.com/scholar?hl=en&as_sdt=1%2C22&as_vis=1&q=%28lung%29+AND+%28cancer+OR+tumor+OR+radiation%29+AND+%28%223D+Slicer%22+OR+%22slicer+org%22+OR+Slicer3D%29+-Slic3r+&btnG= 1,700+ lung]), ([https://scholar.google.com/scholar?hl=en&as_sdt=1%2C22&as_vis=1&q=%28breast%29+AND+%28cancer+OR+tumor+OR+radiation%29+AND+%28%223D+Slicer%22+OR+%22slicer+org%22+OR+Slicer3D%29+-Slic3r+&btnG= 1,300+ breast]) | *[https://scholar.google.com/scholar?hl=en&as_sdt=1%2C22&as_vis=1&q=%28cancer+OR+tumor+OR+radiation%29+AND+%28%223D+Slicer%22+OR+%22slicer+org%22+OR+Slicer3D%29+-Slic3r+&btnG= 5200+ cancer research citations on Google Scholar] ([https://scholar.google.com/scholar?hl=en&as_sdt=1%2C22&as_vis=1&q=%28prostate%29+AND+%28cancer+OR+tumor+OR+radiation%29+AND+%28%223D+Slicer%22+OR+%22slicer+org%22+OR+Slicer3D%29+-Slic3r+&btnG= 1250+ prostate]), ([https://scholar.google.com/scholar?hl=en&as_sdt=1%2C22&as_vis=1&q=%28brain%29+AND+%28cancer+OR+tumor+OR+radiation%29+AND+%28%223D+Slicer%22+OR+%22slicer+org%22+OR+Slicer3D%29+-Slic3r+&btnG= 2,900+ brain]), ([https://scholar.google.com/scholar?hl=en&as_sdt=1%2C22&as_vis=1&q=%28lung%29+AND+%28cancer+OR+tumor+OR+radiation%29+AND+%28%223D+Slicer%22+OR+%22slicer+org%22+OR+Slicer3D%29+-Slic3r+&btnG= 1,700+ lung]), ([https://scholar.google.com/scholar?hl=en&as_sdt=1%2C22&as_vis=1&q=%28breast%29+AND+%28cancer+OR+tumor+OR+radiation%29+AND+%28%223D+Slicer%22+OR+%22slicer+org%22+OR+Slicer3D%29+-Slic3r+&btnG= 1,300+ breast]) | ||
*[https://na-mic.github.io/ProjectWeek/ 32+ events in open source hackathon series] continuously running since 2005 with over 2,400 total participants | *[https://na-mic.github.io/ProjectWeek/ 32+ events in open source hackathon series] continuously running since 2005 with over 2,400 total participants | ||
| − | * [https://discourse.slicer.org/ Slicer Forum] with | + | * [https://discourse.slicer.org/ Slicer Forum] with 2,878 subscribers has approximately 200 posts every week |
<!-- | <!-- | ||
Revision as of 14:36, 25 October 2019
Home < Main Page < SlicerCommunity3D Slicer Enabled Research
3D Slicer is a free open source software package distributed under a BSD style license for analysis, integration, and visualization of medical images. 3D Slicer allows even those with limited image processing experience to effectively explore and quantify their imaging data for hypothesis-driven research.
The community that relies on 3D Slicer is large and active: (numbers below updated on April 22, 2019)
- 575,000+ downloads in the last 8 years (145,000+ in last year)
- over 9,000+ literature search results on Google Scholar
- 5200+ cancer research citations on Google Scholar (1250+ prostate), (2,900+ brain), (1,700+ lung), (1,300+ breast)
- 32+ events in open source hackathon series continuously running since 2005 with over 2,400 total participants
- Slicer Forum with 2,878 subscribers has approximately 200 posts every week
The following is a sample of the research performed using 3D Slicer outside of the group that develops it. (Research performed by groups that are also actively developing 3D Slicer is represented in the publication database).
We invite you to provide information using our discussion forum on how you are using 3D Slicer to produce peer-reviewed research. Information about the scientific impact of this tool is helpful in raising funding for the continued support.
